(cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm) Uses, Dosage, Side Effects and more
(cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm) is under investigation in clinical trial NCT01848106 (A Study to Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI).
| Attribute | Details |
|---|---|
| Trade Name | (cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm) |
| Generic | Anivamersen |
| Anivamersen Other Names | Anivamersen, Rna, (cm-gm-cm-gm-gm-um-am-um-am-gm-um-cm-cm-am-cm) |
| Type | |
| Formula | C157H208N56O103P14 |
| Weight | Average: 4961.313 Monoisotopic: 4958.908624754 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
